☆Velan Capital Investment Management LP
Quality Q
0.318
AUM ($M)
163
Positions
50
Turnover
0.22
Top-10 wt
75%
Herfindahl
0.079
History (qtrs)
6
Excess Return
not eligible
AI Eval Run AI Eval
Holdings · 55 positions · portfolio value $163M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆PRAX funds › | PRAXIS PRECISION MEDICINES I | TRIM | — | 18.2% | -2.1% | 29.7 | 88,781 | -12,000 | 5 | — |
| ☆MPLT funds › | MAPLIGHT THERAPEUTICS INC | HOLD | — | 10.8% | +4.5% | 17.7 | 492,893 | +0 | 3 | — |
| ☆STRO funds › | SUTRO BIOPHARMA INC | HOLD | — | 10.4% | +2.4% | 17.0 | 512,160 | +0 | 3 | — |
| ☆IMMX funds › | IMMIX BIOPHARMA INC | ADD | — | 6.9% | +2.6% | 11.2 | 1,085,000 | +345,000 | 5 | — |
| ☆TARA funds › | PROTARA THERAPEUTICS INC | ADD | — | 6.7% | -2.6% | 10.9 | 2,844,652 | +10,000 | 5 | — |
| ☆ABVX funds › | ABIVAX SA | TRIM | — | 5.4% | -0.0% | 8.7 | 65,630 | -11,370 | 4 | — |
| ☆TENX funds › | TENAX THERAPEUTICS INC | TRIM | — | 4.9% | -0.9% | 8.0 | 549,985 | -33,348 | 5 | — |
| ☆AVR funds › | ANTERIS TECHNOLOGIES GLOBAL | HOLD | — | 4.2% | +1.8% | 6.9 | 700,000 | +0 | 2 | — |
| ☆EDSA funds › | EDESA BIOTECH INC | HOLD | — | 4.1% | +1.4% | 6.7 | 827,500 | +0 | 5 | — |
| ☆EVMN funds › | EVOMMUNE INC | ADD | — | 3.7% | -2.8% | 6.0 | 451,255 | +5,000 | 3 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | ADD | — | 3.7% | +1.9% | 6.0 | 324,452 | +139,330 | 5 | — |
| ☆XNCR funds › | XENCOR INC | ADD | — | 2.5% | +0.6% | 4.1 | 255,000 | +5,000 | 2 | — |
| ☆RZLT funds › | REZOLUTE INC | HOLD | — | 2.4% | +1.0% | 3.9 | 750,000 | +0 | 5 | — |
| ☆HRTX funds › | HERON THERAPEUTICS INC | HOLD | — | 2.3% | -2.1% | 3.7 | 8,753,290 | +0 | 5 | — |
| ☆VRCA funds › | VERRICA PHARMACEUTICALS INC | HOLD | — | 1.8% | +0.2% | 2.9 | 471,559 | +0 | 3 | — |
| ☆CCCC funds › | C4 THERAPEUTICS INC | NEW | — | 1.6% | +1.6% | 2.7 | 570,000 | +570,000 | 1 | — |
| ☆EPRX funds › | EUPRAXIA PHARMACEUTICALS INC | HOLD | — | 1.4% | -0.2% | 2.3 | 352,000 | +0 | 4 | — |
| ☆ADMA funds › | ADMA BIOLOGICS INC | NEW | Common Stock | 1.3% | +1.3% | 2.1 | 250,000 | +250,000 | 1 | — |
| ☆RNTX funds › | REIN THERAPEUTICS INC | NEW | — | 1.1% | +1.1% | 1.8 | 1,700,000 | +1,700,000 | 1 | — |
| ☆LYEL funds › | LYELL IMMUNOPHARMA INC | ADD | — | 0.9% | -0.4% | 1.5 | 105,000 | +3,000 | 2 | — |
| ☆NSRX funds › | NASUS PHARMA LTD | HOLD | — | 0.8% | +0.3% | 1.3 | 359,390 | +0 | 2 | — |
| ☆PROF funds › | PROFOUND MED CORP | TRIM | — | 0.7% | -0.5% | 1.1 | 170,278 | -115,432 | 3 | — |
| ☆JSPR funds › | JASPER THERAPEUTICS INC | HOLD | — | 0.7% | -0.8% | 1.1 | 2,668,395 | +0 | 5 | — |
| ☆PTGX funds › | PROTAGONIST THERAPEUTICS INC | HOLD | — | 0.3% | +0.0% | 0.5 | 3,700 | +0 | 5 | — |
| ☆CTMX funds › | CYTOMX THERAPEUTICS INC. | TRIM | — | 0.3% | -1.3% | 0.5 | 120,000 | -420,000 | 5 | — |
| ☆NMRA funds › | NEUMORA THERAPEUTICS INC. | ADD | — | 0.2% | +0.1% | 0.4 | 230,000 | +150,000 | 2 | — |
| ☆NRIX funds › | NURIX THERAPEUTICS INC | HOLD | — | 0.2% | +0.1% | 0.4 | 16,000 | +0 | 5 | — |
| ☆OVID funds › | OVID THERAPEUTICS INC | TRIM | — | 0.2% | -0.0% | 0.3 | 130,000 | -30,000 | 5 | — |
| ☆DTIL funds › | PRECISION BIOSCIENCES INC | HOLD | — | 0.2% | +0.1% | 0.3 | 40,000 | +0 | 4 | — |
| ☆MLYS funds › | MINERALYS THERAPEUTICS INC | HOLD | — | 0.2% | -0.0% | 0.3 | 11,000 | +0 | 5 | — |
| ☆MGNX funds › | MACROGENICS INC | ADD | — | 0.2% | +0.1% | 0.3 | 60,000 | +30,000 | 2 | — |
| ☆CRBP funds › | CORBUS PHARMACEUTICALS HLDGS | HOLD | — | 0.1% | -0.0% | 0.2 | 26,000 | +0 | 5 | — |
| ☆ARTV funds › | ARTIVA BIOTHERAPEUTICS INC | HOLD | — | 0.1% | +0.0% | 0.2 | 25,000 | +0 | 2 | — |
| ☆REPL funds › | REPLIMUNE GROUP INC | HOLD | — | 0.1% | +0.0% | 0.2 | 20,000 | +0 | 5 | — |
| ☆SNDX funds › | SYNDAX PHARMACEUTICALS INC | HOLD | — | 0.1% | -0.0% | 0.2 | 10,000 | +0 | 4 | — |
| ☆IMNM funds › | IMMUNOME INC | HOLD | — | 0.1% | -0.0% | 0.2 | 10,000 | +0 | 4 | — |
| ☆TECX funds › | TECTONIC THERAPEUTIC INC | NEW | — | 0.1% | +0.1% | 0.2 | 6,000 | +6,000 | 1 | — |
| ☆RCKT funds › | ROCKET PHARMACEUTICALS INC | TRIM | — | 0.1% | -0.5% | 0.2 | 60,000 | -234,643 | 2 | — |
| ☆KPTI funds › | KARYOPHARM THERAPEUTICS INC | ADD | — | 0.1% | +0.1% | 0.2 | 20,000 | +5,000 | 2 | — |
| ☆ANTX funds › | AN2 THERAPEUTICS INC | NEW | — | 0.1% | +0.1% | 0.2 | 40,000 | +40,000 | 1 | — |
| ☆VRDN funds › | VIRIDIAN THERAPEUTICS INC | TRIM | — | 0.1% | -1.0% | 0.2 | 10,000 | -81,123 | 5 | — |
| ☆SCYX funds › | SCYNEXIS INC | NEW | — | 0.1% | +0.1% | 0.2 | 40,000 | +40,000 | 1 | — |
| ☆QNRX funds › | QUOIN PHARMACEUTICALS LTD | TRIM | — | 0.1% | -0.3% | 0.2 | 32,372 | -52,477 | 2 | — |
| ☆XLO funds › | XILIO THERAPEUTICS INC | HOLD | — | 0.1% | +0.0% | 0.1 | 14,285 | +0 | 2 | — |
| ☆NSPR funds › | INSPIREMD INC | TRIM | — | 0.1% | -2.1% | 0.1 | 148,138 | -1,951,514 | 5 | — |
| ☆KLRS funds › | KALARIS THERAPEUTICS INC | ADD | — | 0.1% | -0.0% | 0.1 | 25,000 | +7,000 | 2 | — |
| ☆LRMR funds › | LARIMAR THERAPEUTICS INC | HOLD | — | 0.1% | -0.0% | 0.1 | 33,000 | +0 | 5 | — |
| ☆PRQR funds › | PROQR THRAPEUTICS N V | HOLD | — | 0.1% | +0.0% | 0.1 | 45,000 | +0 | 5 | — |
| ☆CNTX funds › | CONTEXT THERAPEUTICS INC | TRIM | — | 0.0% | -0.1% | 0.0 | 59,700 | -40,300 | 5 | — |
| ☆GOSS funds › | GOSSAMER BIO INC | HOLD | — | 0.0% | -0.0% | 0.0 | 70,000 | +0 | 5 | — |
| ☆PMVP funds › | PMV PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -73,000 | 0 | — |
| ☆KZIA funds › | KAZIA THERAPEUTICS LTD | EXIT | — | 0.0% | -0.6% | 0.0 | 0 | -135,315 | 0 | — |
| ☆DSGN funds › | DESIGN THERAPEUTICS INC | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -20,000 | 0 | — |
| ☆ARWR funds › | ARROWHEAD PHARMACEUTICALS IN | EXIT | — | 0.0% | -0.3% | 0.0 | 0 | -6,500 | 0 | — |
| ☆CUSIP:29664W105 funds › | ESPERION THERAPEUTICS INC NE | EXIT | — | 0.0% | -3.0% | 0.0 | 0 | -1,720,000 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 163 | 50 | 0.22 | 75% | 0.079 | 0.319 | — | in |
| 2026Q1 | 160 | 49 | 0.34 | 73% | 0.079 | 0.146 | — | in |
| 2025Q4 | 172 | 45 | 0.37 | 71% | 0.077 | 0.089 | — | in |
| 2025Q3 | 106 | 49 | 0.45 | 68% | 0.057 | 0.033 | — | in |
| 2025Q2 | 100 | 49 | 0.27 | 70% | 0.064 | 0.152 | — | entered |
| 2025Q1 | 97 | 47 | 0.00 | 77% | 0.071 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status